All News

A nomogram could help to predict patients at risk of Grade 4 neutropenia during treatment, according to a study published in Clinical Genitourinary Cancer.

Selections of our peer-reviewed research and commentary in the healthcare and mainstream press.

The proposal to fund the collaborative care model is part of a broader effort to direct $900 million into primary care, mental health, and care coordination.

Experts at a summit convened by the National Comprehensive Cancer Network (NCCN) agreed that progress in health information technology can help break the walls between compartmentalized data that lives within distinct data systems, to improve patient outcomes.

Lesbian, gay, and bisexual adults reported higher rates of severe psychological distress and impaired physical health than did heterosexuals, according to data from one of the nation’s leading, most representative health surveys.

Details of how Medicare will deliver the Diabetes Prevention Program include efforts to prevent fraud, ensure patient privacy, and tie payment to value-based principles.

What we're reading, July 8, 2016: Aetna will meet with the Department of Justice to discuss Humana purchase; Pfizer will disclose serious risk of addiction when marketing opioids; and US insurers' spending on prescription drugs nearly quadrupled from 2003 to 2014.

The rising prevalence of urologic cancers, along with the increased use of hormone therapies and the approval of novel biologics, is driving strong growth in the urologic cancer market globally through 2022.

The FDA has asked Juno Therapeutics to halt the phase 2 clinical trial of JCAR015 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia, the ROCKET trial.

Body mass index has long been known to be an imperfect instrument; it can declare world class athletes obese while missing people with high body fat on a slender frame.

Panelists at the policy summit hosted by National Comprehensive Cancer Network agreed that sharing information can help create a learning system that can improve patient outcomes.

Yesterday's announcement featured several steps to combat opioid addiction, including expanded access to buprenorphine, steps to educate physicians, and controls on prescription programs through the Department of Defense and the Indian Health Service.

What we're reading, July 7, 2016: the House passed legislation to overhaul mental health care; the NFL is accused of being quick to hand out powerful painkillers; and one student outlines 5 ways to reform medical schools.

A recent study of the Department of Veterans Affairs’ Web-based patient portal, My HealtheVet, found a small, statistically significant and potentially meaningful improvement in diabetes-related physiologic measures among patients who started and sustained use of the portal's features.

The American Society of Clinical Oncology (ASCO) has published a paper that shares the various innovative approaches developed by the society for guideline development and implementation.

Researchers from Washington University in Saint Louis did experiments on mice and found that the effects of high fat, high sucrose diets lasted into the 3rd generation.

A federal appeals court has overturned a previous ruling and decided that biosimilar manufacturers must provide the innovator company a 180-day notice only after receiving FDA-approval for its biosimilar product.

The New Jersey insurer said its fraud fighting efforts included both detective work and analytics. Nationwide, fraud prevention relies increasingly on predictive modeling to keep suspicious payments from ever going out the door.

What we're reading, July 6, 2016: the Department of Veterans Affairs has made progress, but still has a long way to go; court upholds 6-month delay for biosimilars; and Apple promotes organ donation with iPhone app.

About 59 million Americans spent $30.2 billion out-of-pocket on complementary health approaches for adults ($28.3) and children ($1.9) in 2012.

The approval was based on the results of the phase 3 ENDEAVOR study.

Connecticut Insurance Commissioner Katharine L. Wade moved to protect existing policyholders after HealthyCT learned June 30, 2016, it would have to pay CMS $13.4 million under the ACA Risk Adjustment program, which has been heavily criticized.

If the full FDA accepts the panel's narrow recommendation, the type 2 diabetes therapy could enjoy a preferred status above its rivals in the SGLT2 market.

UnitedHealth Group is suing American Renal Associates Holdings for fraudulent behavior, and Anthem and Express Scripts are facing a lawsuit for overcharging on prescription drugs.

Researchers from the Duke Cancer Institute have discovered that mutations in the BRCA1 gene can dramatically increase the probability of a woman developing serous or serous-like endometrial carcinoma.

What we're reading, July 5, 2016: South Carolina's Obamacare health insurance exchange is close to collapse; hepatitis C virus treatment restrictions are being slowly lifted; and a special feature on what foods are healthy.

If dementia goes undiagnosed, people with dementia run the risk of unsafe activities such as driving, cooking, and managing finances and medication.

Gregory C. Simon, executive director, White House Cancer Task Force, spoke at the National Comprehensive Cancer Network Policy Summit, held just 2 days before the Cancer Moonshot Summit.